key: cord-0986544-tvpi25a9 authors: Rodriguez, L. Leonardo; Zimmerman, Karen G. title: Trying Times date: 2020-08-17 journal: CASE (Phila) DOI: 10.1016/j.case.2020.07.001 sha: 7bfe188e747899ab847b73906af5a5b21bcb7fa8 doc_id: 986544 cord_uid: tvpi25a9 nan The world as we know it has changed dramatically. The current COVID-19 pandemic has ravaged the world, stretching health-delivery systems and causing hundreds of thousands of deaths. Our knowledge of the pathophysiology of this disease continues to expand. It appears to be clear now that many of the patients with COVID-19 suffer important cardiovascular complications. They often present venous and arterial thrombosis. In a Dutch study of critically ill patients in the ICU, thromboembolic complications have been seen in 49% of the patients, with pulmonary embolism accounting for the majority of the events. 1 In the current issue of CASE, Horowitz et al. present the detection of a clot in transit using TEE in an ICU patient with COVID-19. Because of the potential for contagion when performing the test, echocardiography has been used sparingly and point-of-care echo has gained relevance. The American Society of Echocardiography has released important statements in regard to the use of POCUS echo 2 and the protection of echocardiography providers during this pandemic. 3 Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19 ASE statement on point-of-care ultrasound during the 2019 novel coronavirus pandemic ASE statement on protection of patients and echocardiography service providers during the 2019 novel coronavirus outbreak: endorsed by the American College of Cardiology Copyright 2020 by the American Society of Echocardiography We hope that the CASE community remains safe and engaged as we move forward in unchartered waters. We sincerely thank all the authors and reviewers who have dedicated their time and effort to help CASE continue in its mission of publishing high-quality educational content.